Cargando…

Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan

BACKGROUND AND AIM: The development of hepatocarcinogenesis after a sustained virological response (SVR) remains an important issue affecting the balance between treatment and occupational life of workers with chronic hepatitis C virus (HCV) infection in Japan. Here, we aimed to evaluate the hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagiwara, Hideki, Ito, Yoshiki, Ohta, Takashi, Nozaki, Yasutoshi, Iwamoto, Takayuki, Hosui, Atsushi, Hiramatsu, Naoki, Tahata, Yuki, Sakamori, Ryotaro, Hikita, Hayato, Hayashi, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218520/ https://www.ncbi.nlm.nih.gov/pubmed/35774345 http://dx.doi.org/10.1002/jgh3.12745

Ejemplares similares

Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
por: Matsumae, Takayuki, et al.
Publicado: (2023)

Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection
por: Morishita, Naoki, et al.
Publicado: (2020)

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
por: Myojin, Yuta, et al.
Publicado: (2022)

Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment
por: Kai, Yugo, et al.
Publicado: (2017)

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C
por: Tahata, Yuki, et al.
Publicado: (2018)

Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
por: Matsumae, Takayuki, et al.
Publicado: (2022)

Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver
por: Nakabori, Tasuku, et al.
Publicado: (2016)

Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis
por: Sakamori, Ryotaro, et al.
Publicado: (2021)

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
por: Maesaka, Kazuki, et al.
Publicado: (2023)

Postoperative bleeding after percutaneous transhepatic gallbladder drainage and aspiration in patients receiving antithrombotic therapy
por: Iwamoto, Takayuki, et al.
Publicado: (2023)

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C
por: Tawara, Seiichi, et al.
Publicado: (2016)

Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review
por: Hyun Sung, Ji, et al.
Publicado: (2021)

Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
por: Shirai, Kumiko, et al.
Publicado: (2022)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
por: Sakane, Sadatsugu, et al.
Publicado: (2021)

Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus
por: Tahata, Yuki, et al.
Publicado: (2023)

The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature
por: Kato, Seiya, et al.
Publicado: (2021)

Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels
por: Sato, Katsuhiko, et al.
Publicado: (2020)

Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration
por: Nozaki, Yasutoshi, et al.
Publicado: (2021)

Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
por: Shirai, Kumiko, et al.
Publicado: (2022)

The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice
por: Yokoyama, Yoshinobu, et al.
Publicado: (2015)

Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis
por: Ikezawa, Kenji, et al.
Publicado: (2017)

A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C
por: Yoshida, Yuji, et al.
Publicado: (2023)

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
por: Suemura, Shigeki, et al.
Publicado: (2019)

Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response
por: Heo, Jeong
Publicado: (2011)

2222. Impact of Sustained Virologic Response Achieved Through Newer Direct Acting Antivirals in Hepatitis C Infection on Diabetes Mellitus
por: Mada, Pradeep Kumar, et al.
Publicado: (2018)

Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy
por: Murai, Kazuhiro, et al.
Publicado: (2022)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
por: Mihai, Florin, et al.
Publicado: (2020)

Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents
por: Mashaal, Ahmed R, et al.
Publicado: (2022)

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
por: Kozumi, Kazuhiro, et al.
Publicado: (2021)

Endoscopic submucosal dissection for early gastric cancer in a patient after left ventricular assist device implantation: A case report
por: Kuriki, Shinji, et al.
Publicado: (2023)

Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver
por: Urabe, Makiko, et al.
Publicado: (2021)

Antiviral Mechanisms: Perspectives in Virology, Volume IX
por: Darling, Tom
Publicado: (1976)

Functional genomics in virology and antiviral drug discovery
por: DeFilippis, Victor, et al.
Publicado: (2003)

Frequency and role of NKp46 and NKG2A in hepatitis B virus infection
por: Yoshioka, Teppei, et al.
Publicado: (2017)

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
por: Liu, Chen-Hua, et al.
Publicado: (2022)

A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response
por: Tada, Toshifumi, et al.
Publicado: (2021)

Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct‐acting antiviral therapy and achieved sustained virological response: The impact of a hepatologist on surveillance
por: Tada, Toshifumi, et al.
Publicado: (2022)

Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non–Cell Autonomous Liver Carcinogenesis
por: Makino, Yuki, et al.
Publicado: (2022)

A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body Myositis
por: Kuwano, Toru, et al.
Publicado: (2018)

Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
por: Noureddin, Mazen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uno8p3tl36g7u59kivhonj0gc7